Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Clinical trial NCT02584933 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02584933
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-11
- Primary completion
- 2027-06-09
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.